Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › HORIZON

ThromboRisk · From cells to systems: Pioneering multi-level thrombosis risk prediction models - “ThromboRisk”

HORIZONStatus: SIGNED1 February 202631 January 2030EU funding €4,436,514Call HORIZON-MSCA-2024-DN-01

Thrombosis, an occlusive blood clot, underlies ischemic stroke, myocardial infarction, and venous thrombosis, causing 1 in 4 deaths globally. Its incidence is rising due to an increasingly aging population and increased cardiovascular diseases, along with more cardiovascular implants. Unfortunately, limited understanding of thrombus formation, growth, and rupture hampers patient-specific prognosis. Current treatment strategies include antithrombotic therapy and thrombectomy, but improvements are needed for patient-specific treatments due to common recurrence and unknown impacts on clot fragmentation and thromboembolism.To effectively understand disease mechanisms and accurately predict treatment outcomes, it is crucial to integrate knowledge across multiple scales, harnessing a diverse range of cutting-edge in silico, in vitro, and in vivo technologies. This powerful fusion of emerging technologies holds the potential to revolutionize targeted and personalized medicine. However, there remains a significant shortage of trained professionals capable of co-creating such comprehensive and holistic disease models. ThromboRisk will therefore train 18 exceptional doctoral candidates (DCs) in diverse scientific fields, including mechanobiology, biochemistry, pathophysiology, and modeling. These researchers will collaborate within an international and interdisciplinary consortium to develop a platform advancing our understanding of thrombosis across scales, hereby bridging the gap between micro-level thrombus processes and macro-level impacts on disease prognosis, enabling clinical application. Unlike traditional engineering curricula, which address well-defined problems, ThromboRisk tackles complex, multifactorial ""wicked problems"" in fields of thrombosis by implementing a Challenge-Based Learning (CBL) doctoral training program to foster creativity, innovation, and societal impact. CBL is growing in undergraduate education but remains underdeveloped in doctoral training, where it has the potential to encourage DCs to step outside their comfort zones, think creatively, manage risks, and use technology responsibly in problem-solving. The DCs will work on real-world problems with peers, supervisors, consortium members, and external stakeholders, who act as ""real clients"" and co-creators.""

Consortium · 18 organisations

coordinator

TECHNISCHE UNIVERSITEIT EINDHOVEN

NL · €610,572

associatedPartner

CorFlow Therapeutics AG

CH

associatedPartner

STICHTING CATHARINA ZIEKENHUIS

NL

associatedPartner

THE UNIVERSITY OF SHEFFIELD

UK

participant

SANO CENTRUM ZINDYWIDUALIZOWANEJ MEDYCYNY OBLICZENIOWEJ MIEDZYNARODOWA FUNDACJA BADAWCZA

PL · €502,302

associatedPartner

SIEMENS SRL

RO

associatedPartner

UNIVERSITAET BERN

CH

participant

UNIVERSITEIT MAASTRICHT

NL · €610,572

participant

UNIVERSITY OF LEEDS

UK · €348,738

associatedPartner

ACADEMISCH ZIEKENHUIS MAASTRICHT

NL

associatedPartner

ROYAL FREE LONDON NHS FOUNDATION TRUST

UK

associatedPartner

STICHTING AMSTERDAM UMC

NL

participant

CHARITE - UNIVERSITAETSMEDIZIN BERLIN

DE · €580,545

associatedPartner

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD

UK

participant

UNIVERSITY COLLEGE LONDON

UK · €697,476

participant

KATHOLIEKE UNIVERSITEIT LEUVEN

BE · €288,540

participant

UNIVERSITATEA TRANSILVANIA DIN BRASOV

RO · €492,485

participant

UNIVERSITEIT VAN AMSTERDAM

NL · €305,286

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.